the influence of the lh-rh agonist ici 118630 on circulating levels of the pituitary gonadotrophins lh and fsh and the gonadal steroids oestradiol , progesterone , 17-hydroxyprogesterone and testosterone has been studied in phase i clinical trials of the drug in patients with advanced breast or prostate cancer .
C0033308
progesterone
C0020387
17-hydroxyprogesterone